Labcorp Holdings Pre-Tax Profit Margin 2012-2025 | LH
Current and historical pre-tax profit margin for Labcorp Holdings (LH) from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Labcorp Holdings pre-tax profit margin for the three months ending December 31, 2025 was .
| Labcorp Holdings Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-12-31 | $13.95B | $1.11B | 7.94% |
| 2025-09-30 | $13.77B | $1.10B | 8.00% |
| 2025-06-30 | $13.48B | $0.98B | 7.23% |
| 2025-03-31 | $13.18B | $0.94B | 7.12% |
| 2024-12-31 | $13.01B | $0.96B | 7.38% |
| 2024-09-30 | $12.71B | $0.63B | 4.95% |
| 2024-06-30 | $12.49B | $0.66B | 5.26% |
| 2024-03-31 | $12.30B | $0.59B | 4.83% |
| 2023-12-31 | $12.16B | $0.57B | 4.68% |
| 2023-09-30 | $11.30B | $0.64B | 5.64% |
| 2023-06-30 | $11.11B | $0.72B | 6.43% |
| 2023-03-31 | $11.00B | $0.87B | 7.91% |
| 2022-12-31 | $11.87B | $1.24B | 10.43% |
| 2022-09-30 | $10.76B | $1.76B | 16.38% |
| 2022-06-30 | $11.96B | $2.22B | 18.52% |
| 2022-03-31 | $12.88B | $2.51B | 19.46% |
| 2021-12-31 | $13.14B | $2.89B | 21.98% |
| 2021-09-30 | $16.56B | $3.68B | 22.25% |
| 2021-06-30 | $16.39B | $3.86B | 23.57% |
| 2021-03-31 | $15.32B | $3.51B | 22.91% |
| 2020-12-31 | $13.98B | $2.22B | 15.87% |
| 2020-09-30 | $12.44B | $1.27B | 10.20% |
| 2020-06-30 | $11.48B | $0.61B | 5.31% |
| 2020-03-31 | $11.59B | $0.58B | 5.02% |
| 2019-12-31 | $11.56B | $1.11B | 9.56% |
| 2019-09-30 | $11.39B | $1.03B | 9.02% |
| 2019-06-30 | $11.29B | $1.24B | 10.98% |
| 2019-03-31 | $11.28B | $1.28B | 11.38% |
| 2018-12-31 | $11.33B | $1.27B | 11.21% |
| 2018-09-30 | $11.29B | $1.32B | 11.70% |
| 2018-06-30 | $11.08B | $1.09B | 9.82% |
| 2018-03-31 | $10.74B | $1.05B | 9.81% |
| 2017-12-31 | $10.31B | $1.08B | 10.45% |
| 2017-09-30 | $9.90B | $1.06B | 10.66% |
| 2017-06-30 | $9.70B | $1.05B | 10.85% |
| 2017-03-31 | $9.60B | $1.09B | 11.30% |
| 2016-12-31 | $9.55B | $1.07B | 11.24% |
| 2016-09-30 | $9.52B | $1.01B | 10.56% |
| 2016-06-30 | $9.42B | $0.99B | 10.56% |
| 2016-03-31 | $9.26B | $0.95B | 10.24% |
| 2015-12-31 | $8.68B | $0.73B | 8.38% |
| 2015-09-30 | $7.89B | $0.73B | 9.28% |
| 2015-06-30 | $7.13B | $0.70B | 9.81% |
| 2015-03-31 | $6.37B | $0.67B | 10.45% |
| 2014-12-31 | $6.01B | $0.82B | 13.66% |
| 2014-09-30 | $5.94B | $0.83B | 14.05% |
| 2014-06-30 | $5.85B | $0.85B | 14.45% |
| 2014-03-31 | $5.80B | $0.86B | 14.87% |
| 2013-12-31 | $5.81B | $0.92B | 15.75% |
| 2013-09-30 | $5.78B | $0.91B | 15.81% |
| 2013-06-30 | $5.73B | $0.91B | 15.87% |
| 2013-03-31 | $5.69B | $0.92B | 16.10% |
| 2012-12-31 | $5.67B | $0.95B | 16.67% |
| 2012-09-30 | $5.63B | $0.98B | 17.37% |
| 2012-06-30 | $5.62B | $0.97B | 17.29% |
| 2012-03-31 | $5.60B | $0.92B | 16.47% |
| 2011-12-31 | $5.54B | $0.87B | 15.63% |
| 2011-09-30 | $5.47B | $0.86B | 15.66% |
| 2011-06-30 | $5.34B | $0.85B | 15.98% |
| 2011-03-31 | $5.18B | $0.91B | 17.52% |
| 2010-12-31 | $5.00B | $0.92B | 18.31% |
| 2010-09-30 | $4.87B | $0.90B | 18.53% |
| 2010-06-30 | $4.78B | $0.91B | 19.01% |
| 2010-03-31 | $4.73B | $0.88B | 18.61% |
| 2009-12-31 | $4.70B | $0.88B | 18.83% |
| 2009-09-30 | $4.65B | $0.87B | 18.71% |
| 2009-06-30 | $4.60B | $0.84B | 18.20% |
| 2009-03-31 | $4.56B | $0.79B | 17.24% |
| 2008-12-31 | $4.51B | $0.79B | 17.45% |
| 2008-09-30 | $4.39B | $0.78B | 17.85% |
| 2008-06-30 | $4.28B | $0.78B | 18.26% |
| 2008-03-31 | $4.17B | $0.82B | 19.63% |
| 2007-12-31 | $4.07B | $0.80B | 19.71% |
| 2007-09-30 | $3.96B | $0.79B | 19.81% |
| 2007-06-30 | $3.85B | $0.78B | 20.28% |
| 2007-03-31 | $3.71B | $0.76B | 20.42% |
| 2006-12-31 | $3.59B | $0.72B | 20.07% |
| 2006-09-30 | $3.52B | $0.70B | 19.80% |
| 2006-06-30 | $3.46B | $0.67B | 19.38% |
| 2006-03-31 | $3.41B | $0.65B | 19.08% |
| 2005-12-31 | $3.33B | $0.64B | 19.27% |
| 2005-09-30 | $3.27B | $0.64B | 19.56% |
| 2005-06-30 | $3.20B | $0.64B | 19.99% |
| 2005-03-31 | $3.13B | $0.63B | 20.15% |
| 2004-12-31 | $3.09B | $0.62B | 19.96% |
| 2004-09-30 | $3.05B | $0.60B | 19.80% |
| 2004-06-30 | $3.02B | $0.58B | 19.34% |
| 2004-03-31 | $2.98B | $0.56B | 18.89% |
| 2003-12-31 | $2.94B | $0.54B | 18.37% |
| 2003-09-30 | $2.86B | $0.50B | 17.46% |
| 2003-06-30 | $2.76B | $0.46B | 16.66% |
| 2003-03-31 | $2.63B | $0.45B | 16.93% |
| 2002-12-31 | $2.51B | $0.43B | 17.23% |
| 2002-09-30 | $2.42B | $0.41B | 16.94% |
| 2002-06-30 | $2.33B | $0.40B | 17.02% |
| 2002-03-31 | $2.27B | $0.36B | 15.89% |
| 2001-12-31 | $2.20B | $0.33B | 14.86% |
| 2001-09-30 | $2.12B | $0.30B | 14.00% |
| 2001-06-30 | $2.05B | $0.27B | 13.37% |
| 2001-03-31 | $1.98B | $0.24B | 12.12% |
| 2000-12-31 | $1.92B | $0.21B | 10.89% |
| 2000-09-30 | $1.86B | $0.19B | 10.40% |
| 2000-06-30 | $1.80B | $0.16B | 8.90% |
| 2000-03-31 | $1.75B | $0.13B | 7.51% |
| 1999-12-31 | $1.70B | $0.11B | 6.24% |
| 1999-09-30 | $1.69B | $0.10B | 5.82% |
| 1999-06-30 | $1.65B | $0.09B | 5.56% |
| 1999-03-31 | $1.61B | $0.09B | 5.28% |
| 1998-12-31 | $1.57B | $0.08B | 5.18% |
| 1998-09-30 | $1.52B | $-0.13B | -8.23% |
| 1998-06-30 | $1.50B | $-0.13B | -8.95% |
| 1998-03-31 | $1.50B | $-0.15B | -9.93% |
| 1997-12-31 | $1.52B | $-0.16B | -10.66% |
| 1997-09-30 | $1.55B | $0.03B | 2.00% |
| 1997-06-30 | $1.58B | $-0.17B | -10.47% |
| 1997-03-31 | $1.60B | $-0.20B | -12.22% |
| 1996-12-31 | $1.61B | $-0.19B | -11.75% |
| 1996-09-30 | $1.62B | $-0.19B | -11.73% |
| 1996-06-30 | $1.64B | $0.02B | 1.16% |
| 1996-03-31 | $1.59B | $-0.01B | -0.50% |
| 1995-12-31 | $1.43B | $0.00B | 0.21% |
| 1995-09-30 | $1.26B | $0.24B | 18.75% |
| 1995-06-30 | $1.10B | $0.21B | 19.45% |
| 1995-03-31 | $0.93B | $0.46B | 49.79% |
| 1994-12-31 | $0.87B | $0.46B | 52.12% |
| 1994-09-30 | $0.81B | $0.23B | 29.00% |
| 1994-06-30 | $0.75B | $0.30B | 39.58% |
| 1994-03-31 | $0.75B | $0.15B | 19.97% |
| 1993-12-31 | $0.76B | $0.19B | 25.10% |
| 1993-09-30 | $0.77B | $0.09B | 11.53% |
| 1993-06-30 | $0.76B | $0.07B | 9.59% |
| 1993-03-31 | $0.75B | $0.07B | 9.26% |
| 1992-12-31 | $0.72B | $0.06B | 8.60% |
| 1992-09-30 | $0.70B | $0.19B | 27.77% |
| 1992-06-30 | $0.67B | $0.19B | 27.97% |
| 1992-03-31 | $0.64B | $0.18B | 28.06% |
| 1991-12-31 | $0.60B | $0.17B | 28.15% |
| 1991-09-30 | $0.58B | $0.16B | 27.95% |
| 1991-06-30 | $0.55B | $0.15B | 27.55% |
| 1991-03-31 | $0.52B | $0.14B | 27.45% |
| 1990-12-31 | $0.50B | $0.14B | 27.35% |
| 1990-06-30 | $0.35B | $0.10B | 28.08% |
| 1990-03-31 | $0.32B | $0.09B | 28.16% |
| 1989-06-30 | $0.27B | $0.08B | 27.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.430B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |